Washington Institute for Coagulation d/b/a WACBD — Seattle, Washington

Washington Institute for Coagulation d/b/a WACBD is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Washington Institute for Coagulation d/b/a WACBD has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hemophilia A, Hemophilia B.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington Institute for Coagulation d/b/a WACBD?

Washington Institute for Coagulation d/b/a WACBD has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington Institute for Coagulation d/b/a WACBD conducted?

Washington Institute for Coagulation d/b/a WACBD has 1 clinical trials on record, with 1 currently active. Their work covers Hemophilia A, Hemophilia B.

Is Washington Institute for Coagulation d/b/a WACBD accredited by Crixeo Health?

Washington Institute for Coagulation d/b/a WACBD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington Institute for Coagulation d/b/a WACBD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.